Quilter PLC Clovis Oncology, Inc. Transaction History

Quilter PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$4.81 - $10.34 $216,483 - $465,372	-45,007 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$4.13 - $6.41 $3,142 - $4,878	-761 Reduced 1.66%	45,007 $216,000
Q2 2020 Aug 12, 2020	SELL	$5.69 - $9.69 $102,220 - $174,080	-17,965 Reduced 28.19%	45,768 $309,000
Q1 2020 May 08, 2020	BUY	$3.77 - $11.0 $240,273 - $701,063	63,733 New	63,733 $405,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Quilter PLC, based on Form 13F filings with the SEC.

Stay updated on Quilter PLC with notifications on news.